BioNTech aims for 2 billion COVID-19 vaccine doses in 2021

German COVID-19 vaccine maker BioNTech, partner of U.S. pharmaceutical group Pfizer , said on Monday it aims to produce two billion doses of its vaccine this year.

"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," BioNTech said in a presentation.